In the past week, TVGN stock has gone down by -14.73%, with a monthly gain of 0.92% and a quarterly surge of 3.77%. The volatility ratio for the week is 15.29%, and the volatility levels for the last 30 days are 7.19% for Tevogen Bio Holdings Inc The simple moving average for the last 20 days is -11.29% for TVGN’s stock, with a simple moving average of -3.91% for the last 200 days.
Is It Worth Investing in Tevogen Bio Holdings Inc (NASDAQ: TVGN) Right Now?
The 36-month beta value for TVGN is at -0.67. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for TVGN is 26.87M, and currently, shorts hold a 7.07% of that float. The average trading volume for TVGN on June 10, 2025 was 886.93K shares.
TVGN) stock’s latest price update
The stock of Tevogen Bio Holdings Inc (NASDAQ: TVGN) has decreased by -23.08 when compared to last closing price of 1.43.Despite this, the company has seen a loss of -14.73% in its stock price over the last five trading days. globenewswire.com reported 2025-06-09 that R&D and cross-functional operations will be centralized in a single location to enhance collaboration and operational efficiency. Tevogen.AI, strengthened by its partnership with Microsoft, continues to expand.
Analysts’ Opinion of TVGN
Many brokerage firms have already submitted their reports for TVGN stocks, with D. Boral Capital repeating the rating for TVGN by listing it as a “Buy.” The predicted price for TVGN in the upcoming period, according to D. Boral Capital is $10 based on the research report published on March 04, 2025 of the current year 2025.
TVGN Trading at -1.36% from the 50-Day Moving Average
After a stumble in the market that brought TVGN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -64.40% of loss for the given period.
#####
#####
Insider Trading
Reports are indicating that there were more than several insider trading activities at TVGN starting from Saadi Ryan H., who sale 1,438,206 shares at the price of $1.23 back on Jun 09 ’25. After this action, Saadi Ryan H. now owns 116,814,453 shares of Tevogen Bio Holdings Inc, valued at $1,768,993 using the latest closing price.
Saadi Ryan H., the Officer of Tevogen Bio Holdings Inc, proposed sale 1,438,206 shares at $1.10 during a trade that took place back on Jun 09 ’25, which means that Saadi Ryan H. is holding shares at $1,582,027 based on the most recent closing price.
Stock Fundamentals for TVGN
Current profitability levels for the company are sitting at:
- -86.75 for the present operating margin
- 0.25 for the gross margin
The net margin for Tevogen Bio Holdings Inc stands at -89.16. The total capital return value is set at 7.4. Equity return is now at value -124.74, with -849.23 for asset returns.
Based on Tevogen Bio Holdings Inc (TVGN), the company’s capital structure generated -0.31 points at debt to capital in total, while cash flow to debt ratio is standing at -7.21. The debt to equity ratio resting at -0.24. The interest coverage ratio of the stock is -9333.73.
Currently, EBITDA for the company is -53.56 million with net debt to EBITDA at 0.0. When we switch over and look at the enterprise to sales, we see a ratio of 509.67. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.35.
Conclusion
In conclusion, Tevogen Bio Holdings Inc (TVGN) has had a better performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
